Ketogenic diet for epilepsy control and enhancement in adaptive behavior

Area of Science:

• Neurology
• Pediatrics
• Nutritional Science

Background:

• Childhood drug-resistant epilepsy (DRE) presents significant management challenges.
• The Ketogenic Diet (KD) is an established therapeutic option for DRE.
• Evaluating KD efficacy and safety in a specific pediatric cohort is crucial.

Purpose of the Study:

• To assess the benefits of the Ketogenic Diet (KD) for pediatric patients with drug-resistant epilepsy (DRE) at Ain Shams University Children's Hospital.
• To evaluate the impact of KD on seizure control, anthropometric measurements, lipid profiles, and adaptive behavior.
• To determine the tolerability and safety of KD in this pediatric population.

Main Methods:

• A cross-sectional study of 143 pediatric patients treated at the Ketoclinic of ASU Children's Hospital.
• Data collection included anthropometric measurements, laboratory data, seizure frequency and severity (Chalfont severity score), and adaptive behavior (Vineland test).
• Statistical analysis was performed to evaluate changes during KD therapy.

Main Results:

• KD therapy led to significant increases in weight and height/length.
• A significant decrease in seizure severity and frequency was observed.
• 65% of patients showed significant improvement in adaptive behavior, with no significant adverse changes in lipid profiles.

Conclusions:

• The Ketogenic Diet (KD) is a safe, tolerable, and effective therapy for drug-resistant epilepsy in children.
• KD positively impacts anthropometric measurements and adaptive behavior in pediatric patients.
• Further long-term studies are recommended to explore potential cognitive benefits of KD in children.